As the Asian markets navigate a landscape marked by regulatory shifts in China and political developments in Japan, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In this context, a good stock is typically characterized by strong fundamentals and resilience to market volatility, offering potential opportunities for those seeking value investments amid the current economic climate.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| WuXi XDC Cayman (SEHK:2268) |
HK$69.10 |
HK$136.34 |
49.3% |
| Simcere Pharmaceutical Group (SEHK:2096) |
HK$11.60 |
HK$22.39 |
48.2% |
| PeptiDream (TSE:4587) |
¥1733.50 |
¥3412.86 |
49.2% |
| Ningxia Building Materials GroupLtd (SHSE:600449) |
CN¥13.01 |
CN¥25.97 |
49.9% |
| Mobvista (SEHK:1860) |
HK$15.96 |
HK$30.71 |
48% |
| Komehyo HoldingsLtd (TSE:2780) |
¥3315.00 |
¥6624.26 |
50% |
| DuChemBIOLtd (KOSDAQ:A176750) |
₩8960.00 |
₩17479.86 |
48.7% |
| Asia-potash International Investment (Guangzhou)Co.Ltd (SZSE:000893) |
CN¥55.30 |
CN¥107.85 |
48.7% |
| Apex Mining (PSE:APX) |
₱14.24 |
₱27.67 |
48.5% |
| Andes Technology (TWSE:6533) |
NT$250.50 |
NT$483.27 |
48.2% |
Let's explore several standout options from the results in the screener.
Shandong Bailong Chuangyuan Bio-Tech
Overview:Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. operates in the biotechnology sector, focusing on the production and sale of bio-based products, with a market cap of CN¥8.93 billion.
Operations:Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. generates its revenue from the biotechnology sector, specializing in bio-based products.
Estimated Discount To Fair Value:14.2%
Shandong Bailong Chuangyuan Bio-Tech's recent financial performance shows robust growth, with net income rising to CNY 264.63 million for the first nine months of 2025. The stock is trading at CNY 21.26, below its estimated fair value of CNY 24.79, indicating potential undervaluation based on cash flows. Although earnings are expected to grow significantly over the next three years, they may lag behind the broader Chinese market's growth rate. Revenue forecasts remain strong at an annual growth rate of 23.3%.
Beijing Beimo High-tech Frictional MaterialLtd
Overview:Beijing Beimo High-tech Frictional Material Co., Ltd specializes in the research, development, production, and sale of brake products for military aircraft and ground equipment with a market cap of CN¥12.27 billion.
Operations:Beijing Beimo High-tech Frictional Material Co., Ltd generates its revenue through the development, manufacturing, and distribution of braking systems specifically designed for military aircraft and ground vehicles.
Estimated Discount To Fair Value:32.9%
Beijing Beimo High-tech Frictional Material Ltd. demonstrates substantial growth potential, with earnings for the first nine months of 2025 rising to CNY 127.54 million from CNY 83.25 million the previous year. The stock trades at CN¥36.98, significantly below its estimated fair value of CN¥55.11, highlighting its undervaluation based on cash flows. Despite a low forecasted return on equity of 12.2%, revenue and earnings are expected to grow well above market rates annually at 34% and over 56%, respectively.
Moriya Transportation Engineering and ManufacturingLtd
Overview:Moriya Transportation Engineering and Manufacturing Co., Ltd. (TSE:6226) specializes in the engineering and manufacturing of transportation systems, with a market cap of ¥95.22 billion.
Operations:Moriya Transportation Engineering and Manufacturing Ltd (TSE:6226) does not provide specific revenue segments in the available data.
Estimated Discount To Fair Value:14.0%
Moriya Transportation Engineering and Manufacturing Ltd. trades at ¥5400, below its estimated fair value of ¥6280.38, indicating undervaluation based on cash flows. Despite recent earnings growth of 52.2%, the stock's future earnings growth is forecasted at 16.4% annually, outpacing the JP market's 8.8%. Revenue is expected to grow by 12% per year, surpassing market rates but not significantly high overall; however, share price volatility remains a concern for investors.
Make It Happen
-
Unlock more gems! Our Undervalued Asian Stocks Based On Cash Flows screener has unearthed 249 more companies for you to explore.Click here to unveil our expertly curated list of 252 Undervalued Asian Stocks Based On Cash Flows .
-
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
-
Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Interested In Other Possibilities?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHSE:605016 SZSE:002985 and TSE:6226.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
